Literature DB >> 20951774

Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.

R C Klein1, B E Mace, S D Moore, P M Sullivan.   

Abstract

Inheritance of the APOE4 allele is a well established genetic risk factor linked to the development of late onset Alzheimer's disease. As the major lipid transport protein in the central nervous system, apolipoprotein (apo) E plays an important role in the assembly and maintenance of synaptic connections. Our previous work showed that 7 month old human apoE4 targeted replacement (TR) mice displayed significant synaptic deficits in the principal neurons of the lateral amygdala, a region that is critical for memory formation and also one of the primary regions affected in Alzheimer's disease, compared to apoE3 TR mice. In the current study, we determined how age and varying APOE genotype affect synaptic integrity of amygdala neurons by comparing electrophysiological and morphometric properties in C57BL6, apoE knockout, and human apoE3, E4 and E2/4 TR mice at 1 month and 7 months. The apoE4 TR mice exhibited the lowest level of excitatory synaptic activity and dendritic arbor compared to other cohorts at both ages, and became progressively worse by 7 months. In contrast, the apoE3 TR mice exhibited the highest synaptic activity and dendritic arbor of all cohorts at both ages. C57BL6 mice displayed virtually identical synaptic activity to apoE3 TR mice at 1 month; however this activity decreased by 7 months. ApoE knockout mice exhibited a similar synaptic activity profile with apoE4 TR mice at 7 months. Consistent with previous reports that APOE2 confers protection, the apoE4-dependent deficits in excitatory activity were significantly attenuated in apoE2/4 TR mice at both ages. These findings demonstrate that expression of human apoE4 contributes to functional deficits in the amygdala very early in development and may be responsible for altering neuronal circuitry that eventually leads to cognitive and affective disorders later in life.
Copyright © 2010 Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951774      PMCID: PMC2991419          DOI: 10.1016/j.neuroscience.2010.10.027

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  58 in total

1.  Mechanisms of amygdala modulation of hippocampal plasticity.

Authors:  Irit Akirav; Gal Richter-Levin
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice.

Authors:  Jean-François Blain; Patrick M Sullivan; Judes Poirier
Journal:  Neurobiol Dis       Date:  2005-09-19       Impact factor: 5.996

4.  Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice.

Authors:  Cristina Osorio; Patrick M Sullivan; Dong Ning He; Brian E Mace; John F Ervin; Warren J Strittmatter; Oscar Alzate
Journal:  Neurobiol Aging       Date:  2006-10-16       Impact factor: 4.673

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  GABAergic innervation of alpha type II calcium/calmodulin-dependent protein kinase immunoreactive pyramidal neurons in the rat basolateral amygdala.

Authors:  Alexander J McDonald; Jay F Muller; Franco Mascagni
Journal:  J Comp Neurol       Date:  2002-05-06       Impact factor: 3.215

7.  Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.

Authors:  K Bohnet; T Pillot; S Visvikis; N Sabolovic; G Siest
Journal:  J Lipid Res       Date:  1996-06       Impact factor: 5.922

8.  ApoE isoform affects LTP in human targeted replacement mice.

Authors:  Barbara L Trommer; Chirag Shah; Sung Hwan Yun; Georgi Gamkrelidze; Emily S Pasternak; Gui Lan Ye; Michelle Sotak; Patrick M Sullivan; Joseph F Pasternak; Mary Jo LaDu
Journal:  Neuroreport       Date:  2004-12-03       Impact factor: 1.837

9.  Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury.

Authors:  A M Fagan; B A Murphy; S N Patel; J F Kilbridge; W C Mobley; G Bu; D M Holtzman
Journal:  Exp Neurol       Date:  1998-06       Impact factor: 5.330

10.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

View more
  33 in total

Review 1.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

Review 2.  The dendritic hypothesis for Alzheimer's disease pathophysiology.

Authors:  J Nicholas Cochran; Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2013-12-12       Impact factor: 4.077

Review 3.  Developmental roles of microglia: A window into mechanisms of disease.

Authors:  Sarah R Anderson; Monica L Vetter
Journal:  Dev Dyn       Date:  2018-12-10       Impact factor: 3.780

4.  Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease.

Authors:  Qiu-Lan Ma; Edmond Teng; Xiaohong Zuo; Mychica Jones; Bruce Teter; Evan Y Zhao; Cansheng Zhu; Tina Bilousova; Karen H Gylys; Liana G Apostolova; Mary Jo LaDu; Mir Ahamed Hossain; Sally A Frautschy; Gregory M Cole
Journal:  Neurobiol Dis       Date:  2018-03-06       Impact factor: 5.996

Review 5.  The role of APOE on lipid homeostasis and inflammation in normal brains.

Authors:  G William Rebeck
Journal:  J Lipid Res       Date:  2017-03-02       Impact factor: 5.922

6.  Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.

Authors:  Stephen Arold; Patrick Sullivan; Tina Bilousova; Edmond Teng; Carol A Miller; Wayne W Poon; Harry V Vinters; Lindsey B Cornwell; Tommy Saing; Gregory M Cole; Karen Hoppens Gylys
Journal:  Acta Neuropathol       Date:  2011-10-22       Impact factor: 17.088

7.  Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.

Authors:  Ingrid Reverte; Fiona Peris-Sampedro; Pia Basaure; Leticia Campa; Cristina Suñol; Margarita Moreno; José Luis Domingo; Maria Teresa Colomina
Journal:  Psychopharmacology (Berl)       Date:  2016-01       Impact factor: 4.530

Review 8.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

9.  Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.

Authors:  Sarah K Woody; Helen Zhou; Shaher Ibrahimi; Yafeng Dong; Liqin Zhao
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

10.  Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.

Authors:  Rebecca C Klein; Shawn K Acheson; Brian E Mace; Patrick M Sullivan; Scott D Moore
Journal:  Neurobiol Aging       Date:  2014-03-02       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.